Literature DB >> 24423967

Paediatric dilated cardiomyopathy: clinical profile and outcome. The experience of a tertiary centre for paediatric cardiology.

Joana O Miranda1, Liane Costa2, Esmeralda Rodrigues3, Elisa L Teles3, Maria J Baptista1, José C Areias1.   

Abstract

Dilated cardiomyopathy is the most common form of cardiomyopathy in the paediatric population and an important cause of heart transplantation in children. The clinical profile and course of dilated cardiomyopathy in children have been poorly characterised. A retrospective review of 61 patients (37 female; 24 male) diagnosed with dilated cardiomyopathy from January, 2005 to June, 2012 at a single institution was performed. The median age at diagnosis was 15 months. Heart failure was present in 83.6% of patients and 44.3% required intensive care. The most prevalent causes were idiopathic (47.5%), viral myocarditis (18.0%) and inherited metabolic diseases (11.5%). In viral myocarditis, Parvovirus B19 was the most common identified agent, in concurrence with the increasing incidence documented recently. Inherited metabolic diseases were responsible for 11.5% of dilated cardiomyopathy cases compared with the 4-6% described in the literature, which reinforces the importance of considering this aetiology in differential diagnosis of paediatric dilated cardiomyopathy. The overall mortality rate was 16.1% and five patients underwent heart transplantation. In our series, age at diagnosis and aetiology were the most important prognosis factors. We report no mortality in the five patients who underwent heart transplantation, after 2 years of follow-up.

Entities:  

Keywords:  metabolic disease

Mesh:

Substances:

Year:  2014        PMID: 24423967     DOI: 10.1017/S1047951113002369

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  6 in total

1.  Evaluation of the diagnostic work-up in children with myocarditis and idiopathic dilated cardiomyopathy.

Authors:  S L den Boer; R P J Meijer; G G van Iperen; A D J Ten Harkel; G J du Marchie Sarvaas; B Straver; L A J Rammeloo; R B Tanke; J J A van Kampen; M Dalinghaus
Journal:  Pediatr Cardiol       Date:  2014-09-07       Impact factor: 1.655

Review 2.  Myocarditis in Paediatric Patients: Unveiling the Progression to Dilated Cardiomyopathy and Heart Failure.

Authors:  Inês Teixeira Farinha; Joana Oliveira Miranda
Journal:  J Cardiovasc Dev Dis       Date:  2016-11-08

Review 3.  Systematic Review of PCR Proof of Parvovirus B19 Genomes in Endomyocardial Biopsies of Patients Presenting with Myocarditis or Dilated Cardiomyopathy.

Authors:  Angelos G Rigopoulos; Bianca Klutt; Marios Matiakis; Athanasios Apostolou; Sophie Mavrogeni; Michel Noutsias
Journal:  Viruses       Date:  2019-06-18       Impact factor: 5.048

Review 4.  Clinical and biochemical footprints of inherited metabolic diseases. IV. Metabolic cardiovascular disease.

Authors:  Carlos R Ferreira; Nenad Blau
Journal:  Mol Genet Metab       Date:  2020-12-25       Impact factor: 4.797

5.  Parameters affecting outcome of paediatric cardiomyopathies in the intensive care unit: experience of an Egyptian tertiary centre over 7 years.

Authors:  Alaa A Sobeih; Sonia A El-Saiedi; Noha S Abdel Khalek; Shereen A Attia; Baher M Hanna
Journal:  Libyan J Med       Date:  2020-12       Impact factor: 1.657

6.  Do we know the limits of the heart?

Authors:  Marc Figueras-Coll; Anna Sabaté-Rotés; Ferran Gran-Ipiña; Ferran Rosés-Noguer
Journal:  Arch Cardiol Mex       Date:  2022-04-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.